Psoriatic Arthritis Resource Center

skin, psoriatic arthritis, Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

Joint and Skin Symptoms Make Quality of Life Significantly Worse for Psoriatic Arthritis Patients

A study ascertained the effect of joint and skin symptoms on psoriatic arthritis (PsA) patients and found that they contribute significantly to poorer clinical...
Psoriatic Arthritis Detection in Psoriasis: How Can Rheumatologists Identify the Disease?

Psoriatic Arthritis Detection in Psoriasis: How Can Rheumatologists Identify the Disease?

Early psoriatic arthritis detection can pose a challenge for rheumatologists—especially in the presence of psoriasis. A study assessed the correlation between serological markers and...
rheum, treatment, diet, IBD, arthritis, vitamin D deficiency, deficiency, depression, RA Causes, Reducing Opioid Use in Back Pain, Arthritis and Mental Health, Do Men and Women Report OA Pain Differently?, and More

Rheum Round-up: Bimekizumab in Active PsA, Which Surgeries Result in ‘Surprise’ Medical Bills?, and...

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about the use of bimekizumab in...
skin, psoriatic arthritis, Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

Bimekizumab Is a Safe and Effective Treatment for Active Psoriatic Arthritis

The randomized, double-blind BE ACTIVE trial compared bimekizumab versus placebo in patients with active psoriatic arthritis. According to the findings, bimekizumab was associated with...
trump, Hydroxychloroquine, hip arthroplasty, covid-19, postoperative, cancellations, rheumatologists, voltaren, fracture, opioids, TXA, JIA, pain, disease, frailty, violence, rheumatic, acr, cbd, NSAIDs, humira, knee, TJA

Rheum Round-up: Interview with Researchers, Which Patients Have More Medical Visits?, and more

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an interview with two researchers behind...
skin, psoriatic arthritis, Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

PsA Patients Have More Medical Visits in Five Years Leading Up to Diagnosis

A new study evaluated healthcare utilization among psoriatic arthritis (PsA) patients in the years leading up to their diagnosis. The researchers concluded here that...
skin, psoriatic arthritis, Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

Five-year Efficacy of Secukinumab in PsA

Patients with psoriatic arthritis (PsA) may observe improved long-term outcomes with secukinumab treatment, according to the results of a five-year study. “Biologic therapies, such as...

Curated Journal Reading List

click me
--> -->